-+ 0.00%
-+ 0.00%
-+ 0.00%

GUARDANT HEALTH’S INFINITYAI REAL-WORLD EVIDENCE SUPPORTS APPROVAL OF ENHERTU® FOR PREVIOUSLY TREATED PATIENTS WITH HER2-POSITIVE METASTATIC SOLID TUMORS IN JAPAN

Reuters·03/30/2026 12:05:06

Please log in to view news